Alzheimer's Drug Helps Slow Down Development—Eisai, Biogen Proves in Clinical Trial It is a new cutting edge development to medicine in treating people with dementia. by Isaiah Richard
Health FDA Approves Alzheimer's Drug Known as 'Aducanumab,' Which Target Dementia Forms Over Symptoms by Isaiah Richard